Royal Bank of Canada
JAZZ icon

Royal Bank of Canada’s Jazz Pharmaceuticals JAZZ Stock Holding History

Royal Bank of Canada’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,300
Closed -$493K – 6841
2019
Q4 		$493K Buy
+3,300
New +$449K ﹤0.01% 4003
2016
Q1 		– Sell
-30,000
Closed -$4.22M – 6505
2015
Q4 		$4.22M Buy
+30,000
New +$4.16M ﹤0.01% 1973

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Royal Bank of Canada's JAZZ Position: Q1 2026 in Review

Royal Bank of Canada increased its Jazz Pharmaceuticals (JAZZ) stake by 17% in Q1 2026, buying an estimated $1.17M and bringing the position to 45,251 shares worth $8.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

Royal Bank of Canada first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $69.2M in Q4 2016. 573 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Royal Bank of Canada held 45,251 shares of Jazz Pharmaceuticals worth $8.56M as of Q1 2026.
  • Royal Bank of Canada bought 6,695 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.17M.
  • Jazz Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2022 holding.
  • Royal Bank of Canada first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Jazz Pharmaceuticals position peaked at $69.2M in Q4 2016.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.